Hobart Group Holdings LLC 2014
|Active business clients||15|
|Brands by 2013 sales|
|Brand-product accounts held||16|
|Payer access and reimbursement||100%|
Abbott Diabetes Care
Founded during 2003 with one client and $200,000 in revenue, Hobart Group Holdings has since grown into a $30+ million company with close to 150 employees across three locations managing business for a variety of large, midsize, and emerging biopharmaceutical companies.
“Our incredible and sustained growth over the past 10 years stems from a culture that thrives on the passion to develop novel approaches to improving patient care through innovative customer initiatives,” says Dan Renick, R.Ph., president of Hobart Group Holdings. “Hobart has always been, and will continue to be, the agency to raise the bar, set the trends, and create new approaches in the managed markets space.”
The Year’s Accomplishments
Executives say Hobart Group Holdings provides comprehensive access and reimbursement support to a client base that includes six of the top 10 global biopharma companies. The company’s growth has not gone unrecognized. In recent years, Hobart has received many accolades. During 2011 and 2012, Hobart was listed in Inc. magazine’s top 500/5000 Fastest Growing Companies; in 2012 and 2013, Hobart was honored as one of the Best Places to Work in New Jersey; and in 2013, Hobart was nominated as Agency of the Year by Med Ad News
In 2013, the company grew by 28 percent, driven by organic growth and several new client wins, resulting in 20 new products and above brand business. To help manage this extensive growth, Hobart added 34 employees across all offices and promoted several key executives. The three agency leads, Carlos Delucca of the Hobart Group, Kelly Wilder of Hobart Forte/Hobart Core, and Larry Blandford, Pharm.D., of Hobart Innovations, were promoted to managing partners in recognition of their significant and expanded leadership responsibilities. Dan Vanderpoel, Pharm.D., senior VP, became head of Hobart Core in Chicago. Tom McCann was promoted to senior VP of strategic services, leading payer insights for specialty pharmacy and biotech.
A key addition to Hobart included Dominic Galante, M.D., as chief medical officer. Dr. Galante joined Hobart after an extensive career in managed care executive leadership roles. He recently served as VP of medical quality management at MVP Health Care.
Structure And Services
As the largest dedicated payer agency in the United States, Hobart Group Holdings has provided strategic and tactical partnership services to its broad client base for more than a decade. Hobart’s services include developing meaningful payer value propositions, payer-focused launch planning, payer market research, quality initiatives, HEOR support, managed markets sales training, and extensive contracting and pricing expertise.
Hobart executives say the agency recognizes strategic real-world payer insight as the foundation for creating meaningful market solutions and integrates this insight into all strategic, tactical, and creative development. Led by Blandford, the strategic services department brings market insight gained through a diverse compilation of hands-on industry experience across multiple segments within managed markets. Team members have held leadership roles at some of the nation’s largest and most influential payers, including commercial health plans, Part D sponsors, PBMs, benefit consulting firms, provider systems, and alternate care sites. In addition, several individuals on the team offer extensive pharmaceutical manufacturer marketing experience as well as agency expertise in managed care marketing and market research.
Hobart’s growth comes from the understanding that without innovation, irrelevancy sets in, especially in a rapidly evolving market where provider systems and patients increasingly assume healthcare risk and share in decision making. As a result, the company has consistently developed new and unique client offerings, hired new talent, opened new offices, and forged new partnerships. “The foundation for this success is a company culture and set of guiding principles that start with the commitment to deliver quality, creativity, and innovation to every client every day,” executives say.
Agency leaders believe that two major areas of evolution will become more important in 2014, as Hobart builds on its initial pricing and market access work outside of the United States, and expands on current strategic payer marketing to include greater scientific and technical capabilities, specifically in the areas of evidence generation and advanced analytics. “Both the geographic and capabilities expansion reflect the realities of a global, data-driven market access environment along with frequent client requests to broaden the existing strong partnerships we so highly value,” Renick says.
In 2013, Hobart made a substantial donation and commitment to Bonnie Brae Transitional School. Bonnie Brae is a residential school and therapeutic community for New Jersey boys, ages 8-18, in crisis. It is a nationally accredited residential treatment center equipped with teams of clinicians, special education teachers, and highly trained residential staff to give individualized mental health, educational, physical, and residential care to the students. Bonnie Brae’s mission is to be a haven where young men reclaim their potential through education and therapy.
“Hobart is not only a proud supporter, but a champion of Bonnie Brae’s mission. The institution’s success with providing the boys a foundation for a brighter future is astounding,” Delucca says. “It is critical for New Jersey businesses to support institutions like Bonnie Brae – when the students succeed, we all succeed.”
Hobart also continued its ongoing commitment to giving back to the local community through several initiatives. The agency supported the Matheny School in Gladstone for the disabled, the United Way’s Gifts of the Season program, and Jersey Cares’ 18th Annual Coat Drive.
Ad Right Top
Extensive pharmaceutical business
October 2015 Focus: Top 50 Pharma